X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 58 filers reported holding X4 PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,174,690 | -67.7% | 1,995,128 | -42.5% | 0.00% | -100.0% |
| Q2 2023 | $6,731,216 | +4706.8% | 3,469,699 | +2055.6% | 0.00% | – |
| Q1 2023 | $140,036 | -87.5% | 160,961 | -85.7% | 0.00% | – |
| Q4 2022 | $1,120,455 | +463.0% | 1,128,353 | +867.7% | 0.00% | – |
| Q3 2022 | $199,000 | +101.0% | 116,600 | +14.1% | 0.00% | – |
| Q2 2022 | $99,000 | -59.6% | 102,154 | -27.0% | 0.00% | – |
| Q1 2022 | $245,000 | -35.5% | 140,014 | -15.7% | 0.00% | – |
| Q4 2021 | $380,000 | +7.0% | 166,000 | +148.0% | 0.00% | – |
| Q3 2021 | $355,000 | -22.3% | 66,932 | -4.8% | 0.00% | – |
| Q2 2021 | $457,000 | +294.0% | 70,273 | +505.7% | 0.00% | – |
| Q1 2020 | $116,000 | – | 11,602 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 12,202,510 | $10,616 | 1.33% |
| Tri Locum Partners LP | 3,878,484 | $3,374,281 | 1.03% |
| Lynwood Capital Management Inc. | 900,000 | $783,000 | 0.71% |
| NEA Management Company, LLC | 11,736,793 | $10,211,010 | 0.71% |
| Parkman Healthcare Partners LLC | 2,797,147 | $2,433,518 | 0.53% |
| SCOGGIN MANAGEMENT LP | 484,796 | $567,025 | 0.33% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $291,450 | 0.24% |
| Ghost Tree Capital, LLC | 850,000 | $740,000 | 0.22% |
| Perceptive Advisors | 4,545,454 | $3,954,545 | 0.12% |
| Orbimed Advisors | 5,817,726 | $5,061,422 | 0.10% |